Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total Shareholders' Equity [Member]
Non-controlling Interest [Member]
Total
Beginning balance at Oct. 31, 2019 $ 203,317 $ 186,849,299 $ (181,817,263) $ 5,235,353 $ (422,975) $ 4,812,378
Beginning balance, shares at Oct. 31, 2019 20,331,754          
Stock option compensation to employees and directors 2,019,211 2,019,211 2,019,211
Stock options and warrants issued to consultants 112,209 112,209 112,209
Common stock issued upon exercise of stock options $ 439 103,291 103,730 103,730
Common stock issued upon exercise of stock options, shares 43,900          
Common stock issued pursuant to employee stock purchase plan $ 96 15,356 15,452 15,452
Common stock issued pursuant to employee stock purchase plan, shares 9,618          
Common stock issued in at-the-market offering, net of offering expenses $ 10,941 3,022,894 3,033,835 3,033,835
Common stock issued in at-the-market offering, net of offering expenses, shares 1,094,063          
Net loss (5,232,636) (5,232,636) (41,929) (5,274,565)
Ending balance at Apr. 30, 2020 $ 214,793 192,122,260 (187,049,899) 5,287,154 (464,904) 4,822,250
Ending balance, shares at Apr. 30, 2020 21,479,335          
Beginning balance at Jan. 31, 2020 $ 208,413 189,646,000 (184,409,806) 5,444,607 (447,007) 4,997,600
Beginning balance, shares at Jan. 31, 2020 20,841,309          
Stock option compensation to employees and directors 1,055,331 1,055,331 1,055,331
Stock options and warrants issued to consultants 54,755 54,755 54,755
Common stock issued upon exercise of stock options $ 250 75,000 75,250 75,250
Common stock issued upon exercise of stock options, shares 25,000          
Common stock issued pursuant to employee stock purchase plan $ 96 15,356 15,452 15,452
Common stock issued pursuant to employee stock purchase plan, shares 9,618          
Common stock issued in at-the-market offering, net of offering expenses $ 6,034 1,275,818 1,281,852 1,281,852
Common stock issued in at-the-market offering, net of offering expenses, shares 603,408          
Net loss (2,640,093) (2,640,093) (17,897) (2,657,990)
Ending balance at Apr. 30, 2020 $ 214,793 192,122,260 (187,049,899) 5,287,154 (464,904) 4,822,250
Ending balance, shares at Apr. 30, 2020 21,479,335          
Beginning balance at Oct. 31, 2020 $ 242,486 200,354,488 (191,835,618) 8,761,356 (496,983) 8,264,373
Beginning balance, shares at Oct. 31, 2020 24,248,695          
Stock option compensation to employees and directors 1,755,638 1,755,638 1,755,638
Stock options and warrants issued to consultants 281,733 281,733 281,733
Common stock issued upon exercise of stock options $ 1,075 292,529 293,604 $ 293,604
Common stock issued upon exercise of stock options, shares 107,451         44,000
Common stock issued pursuant to employee stock purchase plan $ 16 2,984 3,000 $ 3,000
Common stock issued pursuant to employee stock purchase plan, shares 1,634          
Common stock issued in a public offering, net of offering expenses $ 42,858 20,248,996 20,291,854 20,291,854
Common stock issued in a public offering, net of offering expenses, shares 4,285,715          
Common stock issued in at-the-market offering, net of offering expenses $ 28,064 10,805,651 10,833,715 10,833,715
Common stock issued in at-the-market offering, net of offering expenses, shares 2,806,410          
Net loss (4,607,142) (4,607,142) (62,124) (4,669,266)
Ending balance at Apr. 30, 2021 $ 314,499 233,742,019 (196,442,760) 37,613,758 (559,107) 37,054,651
Ending balance, shares at Apr. 30, 2021 31,449,905          
Beginning balance at Jan. 31, 2021 $ 261,791 207,382,102 (194,043,909) 13,599,984 (521,069) 13,078,915
Beginning balance, shares at Jan. 31, 2021 26,179,122          
Stock option compensation to employees and directors 880,776 880,776 880,776
Stock options and warrants issued to consultants 170,496 170,496 170,496
Common stock issued upon exercise of stock options $ 776 188,604 189,380 189,380
Common stock issued upon exercise of stock options, shares 77,571          
Common stock issued pursuant to employee stock purchase plan $ 16 2,984 3,000 3,000
Common stock issued pursuant to employee stock purchase plan, shares 1,634          
Common stock issued in a public offering, net of offering expenses $ 42,858 20,248,996 20,291,854 20,291,854
Common stock issued in a public offering, net of offering expenses, shares 4,285,715          
Common stock issued in at-the-market offering, net of offering expenses $ 9,058 4,868,061 4,877,119 4,877,119
Common stock issued in at-the-market offering, net of offering expenses, shares 905,863          
Net loss (2,398,851) (2,398,851) (38,038) (2,436,889)
Ending balance at Apr. 30, 2021 $ 314,499 $ 233,742,019 $ (196,442,760) $ 37,613,758 $ (559,107) $ 37,054,651
Ending balance, shares at Apr. 30, 2021 31,449,905